Envision Healthcare (NYSE: EVHC) and iKang Healthcare Group (NASDAQ:KANG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.
This table compares Envision Healthcare and iKang Healthcare Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|iKang Healthcare Group||3.16%||4.97%||2.30%|
This is a breakdown of recent recommendations and price targets for Envision Healthcare and iKang Healthcare Group, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|iKang Healthcare Group||0||0||0||0||N/A|
Envision Healthcare presently has a consensus target price of $40.61, indicating a potential upside of 5.53%. Given Envision Healthcare’s higher possible upside, equities analysts clearly believe Envision Healthcare is more favorable than iKang Healthcare Group.
Volatility & Risk
Envision Healthcare has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, iKang Healthcare Group has a beta of 0.07, indicating that its stock price is 93% less volatile than the S&P 500.
Institutional and Insider Ownership
33.5% of iKang Healthcare Group shares are owned by institutional investors. 3.1% of Envision Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation & Earnings
This table compares Envision Healthcare and iKang Healthcare Group’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Envision Healthcare||$12.18 billion||0.38||-$228.00 million||$2.48||15.52|
|iKang Healthcare Group||$435.71 million||3.17||-$11.25 million||N/A||N/A|
iKang Healthcare Group has lower revenue, but higher earnings than Envision Healthcare.
iKang Healthcare Group beats Envision Healthcare on 7 of the 12 factors compared between the two stocks.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The company also offers ambulatory surgical centers (ASCs) services that provide surgical procedures across multiple specialties, including gastroenterology, ophthalmology, orthopedics, and others. It operated 264 ASCs in 35 states and the District of Columbia. In addition, it provides surgery services, such as management, oversight, and surgeon staffing for trauma surgery services; offers direct patient care and care coordination by clinicians outside the acute care setting through physician-led post-acute care services; and operates office-based medical practices that primarily focus on women's health, as well as provides physician staffing and related management services. Further, it offers medical transportation services in 41 states and the District of Columbia. The company offers its clinical solutions for health systems, payors, providers, and patients. Envision Healthcare Corporation was founded in 1992 and is based in Nashville, Tennessee.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc., together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items. The company also provides value-added services at selected medical centers, such as disease screening focusing on cancer screening, cardiovascular and chronic disease screening, and functional medicine testing; dental care comprising oral health, pediatric and cosmetic dentistry, orthodontics, and dental implants; outpatient services, which consists of acupuncture, Chinese medicine, gynecology, internal medicine, obstetrics, ophthalmology, pediatrics, urology, and minor surgery; and on-site healthcare management or clinical services. It primarily serves corporate and individual customers through a network of self-owned medical centers and the facilities of third-party service providers. As of July 28, 2017, it owned and operated a network of 108 self-owned medical centers in 33 cities of China, including Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu, Fuzhou, Changchun, Jiangyin, Changzhou, Wuhan, Changsha, Yantai, Yinchuan, Weihai, Weifang, Shenyang, Xi'an, Wuhu, Guiyang, Ningbo, Foshan, Jinan, Bijie, Qingdao, Wuxi, Kaili, Mianyang, and Hong Kong. The company was formerly known as China iKang Healthcare, Inc. and changed its name to iKang Healthcare Group, Inc. in February 2014. iKang Healthcare Group, Inc. is headquartered in Beijing, the People's Republic of China.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.